Bill Text: US HB4242 | 2023-2024 | 118th Congress | Introduced


Bill Title: To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to issue guidance on considerations for conducting clinical trials for psychedelic assisted therapy.

Spectrum: Slight Partisan Bill (Republican 2-1)

Status: (Introduced) 2023-06-23 - Referred to the Subcommittee on Health. [HB4242 Detail]

Download: US_Congress-2023-HB4242-Introduced.pdf
It appears your computer is unable to display this document, however you can download the file from the links above.
feedback